Filter Results
Clinical Studies
Results filtered:Study status:
Closed for Enrollment
Closed for Enrollment
-
A Phase IV, Randomized, Open Label, Multicenter, Prospective Comparative Study to Evaluate the Efficacy and Safety of Edoxaban or Warfarin Therapy in Cardiovascular Implantable Electrical Device Procedures in Patients with Non-Valvular Atrial Fibrillation (ENTICED-AF)
Scottsdale/Phoenix, Ariz.
The purpose of this study is to compare the safety and effectiveness of Edoxaban to Warfarin when used in patients with a non-valve related atrial fibrillation undergoing clinically indicated implantation or replacement of cardiovascular implantable electrical devices.
-
Comparison of Hypertrophic Cardiomyopathy Candidate Gene Homologs in Human and Rhesus Macaque Sudden Cardiac Death Victims
Scottsdale/Phoenix, Ariz.
The aim of this study is to identify genes shared between humans and rhesus macaque primates who have been diagnosed with hypertrophic cardiomyopathy and have died suddenly.
-
Comparison of Hypertrophic Cardiomyopathy Candidate Gene Homologs in Human and Rhesus Macaque Sudden Cardiac Death Victims
Scottsdale/Phoenix, Ariz.
This study is designed to identify genes shared between humans with hypertrophic cardiomyopathy and rhesus macaque primates who have experienced sudden cardiac death.
-
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia to Sinus Rhythm (NODE-1)
Scottsdale/Phoenix, Ariz.
The primary objective of this study is to demonstrate the superiority of at least 1 dose of intranasal MSP-2017 over placebo in terminating paroxysmal supraventricular tachycardia induced in an electrophysiology laboratory
.